Skip to main content

Case Comprehensive Cancer Center

cancer-cells-feat
Case Comprehensive Cancer Center annual scientific retreat TED-style Talks
The Case Comprehensive Cancer Center will open up part of its virtual annual scientific retreat to the general public today (July 22). Members of the community are invited to tune in at noon to hear an update from Cancer Center Director Stan Gerson followed by TED-style Talks from prominent…
Summer Training Programs Offer Valuable Experience in Virtual Format
Sparking a young person’s interest in science is exciting, though it takes creativity and adaptability. That statement was most true in 2020, when the Cancer Center’s summer training program directors were forced to change course during the COVID-19 pandemic. Teamwork, dedication and creativity…
Fran-Noonan.jpeg
For Glioblastoma Patient, Clinical Trial Gives Optimal Results
When Fran Noonan was told she would have the opportunity to enroll in a new clinical trial for glioblastoma multiforme (GBM), she could not get to Cleveland fast enough. She put her full trust in Andrew Sloan, MD, and his team, and, to use Noonan’s words, “the results have been a miracle.” Two…
Top TEN reasons to attend the annual scientific retreat
The Annual Cancer Center Scientific Retreat is next week, July 22-23, and we encourage you to attend!  Hear TED-style Talks from Cleveland leaders: Diana Bilimoria, PhD, Serpil Erzurum, MD and Dan Spratt, MD. These talks are always insightful and a great way to set the tone for the retreat! They…
Gupta appointed director of genitourinary medical oncology, Taussig Cancer Institute
The Case Comprehensive Cancer Center extends congratulations to Shilpa Gupta, MD on her appointment to director of genitourinary medical oncology at Taussig Cancer Institute and co-leader of the genitourinary oncology program at Cleveland Clinic. Dr. Gupta is a member of the Case Comprehensive…
Schiemann%20W2_crop.jpg
Researchers uncover new understanding of cancer cell telomere survival mechanisms
Case Comprehensive Cancer Center-led research has potential for development of new cancer treatment targets. Research published in “Science Signaling” identifies new ways that telomeres regulate the aggressiveness and survival of tumors, making them potentially vulnerable therapeutic targets for…
Grant submissions policy change, other support template overhaul, updates requested by October 1
NIH’s required Other Support documentation has undergone a complete overhaul. The Cancer Center regularly needs members’ Other Support (OS) documents for grant submissions and progress reports, and we need to update our OS repository with your new OS documentation. Please note that the new OS…
Investment in Immunotherapy Spurs Growth
The recruitment of world-class talent and investment in new technology position Cleveland as a leader in immunotherapy, the future of cancer care. Cleveland’s immunotherapy hubs are undergoing significant growth. Cleveland Clinic and MetroHealth Medical Center are developing new programs led by new…
cancer-cells-feat
Memorial gift to fund cutting-edge cancer research
The Case Comprehensive Cancer Center (Case CCC) received a $250,000 gift from brothers Lorne and Eric Novick to fund a cutting-edge, collaborative research study. The Andrew Novick Study on Artificial Intelligence and Epigenomics for Cancer Disparities, which honors the Novicks’ late father, pairs…
Spartan Showcase: Manav Midha
Year: Rising junior Major: Economics, pre-med Minor: Chemistry Growing up, Case Western Reserve University rising junior Manav Midha found himself torn between focusing his career goals on medicine—having the humbling power to save lives—or economics—understanding how incentives shape our…